This site contains promotional information intended only for healthcare professionals resident in the United Kingdom

Visit Pfizer Medical site

Menu

Close

Sign InLog Out
  • EN
Single LinkDropdownLabelLinkLinkLinkLinkLinked DropdownLabelLinkLinkLinkLinkMega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
Linked Mega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
EN - EnglishSelect a languageLanguagesEN - EnglishFR - Françias

Menu

Close

Sign InLog Out
  • EN
Single LinkDropdownLabelLinkLinkLinkLinkLinked DropdownLabelLinkLinkLinkLinkMega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
Linked Mega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
EN - EnglishSelect a languageLanguagesEN - EnglishFR - Françias
Search

Menu

Close

Sign In or RegisterLog Out
Pfizer MedicinesTherapy AreasExplore ContentEventsVideosMaterialsFeatured ArticlesLet’s ConnectSupplyAlliance HealthcareOff-contract claims

Adverse event reporting can be found at the bottom of the page

About

ButtonLoadingMOA

About

AboutAlopecia AreataBurden of Alopecia AreataMOA
EfficacySafety ProfileOverviewSALT score ≤10SALT score ≤20PGI-CEyebrow and Eyelash ResponsesBefore and After Patient ImagesSafety ProfileSafety ProfileContraindications, Special Warnings and PrecautionsAdverse ReactionsPatient ProfilesGetting Started
Getting StartedDosingLaboratory Parameter Monitoring
ResourcesResourcesVideos
Materials

Click here for LITFULO (ritlecitinib) Prescribing Information

Alopecia Areata

Burden of Alopecia Areata

Mode of Action

Alopecia areata has been associated with impaired health-related quality of life,1,2 psychosocial burden3 and stigma4,7 

Alopecia areata (AA) has been associated with poor health-related quality of life.1,2 Hair loss can be emotionally devastating and lead to depression, anxiety and low self-esteem.3

Coping with AA can be  a daily challenge that  may cause psychosocial insecurities.3,4 Patients may feel anxious and  self-conscious in social situations and socially withdraw.3,5,6

In adolescents, AA may affect school attendance3,6 and performing poorly.3

AA may also affect adults in their professional lives and in terms of finding employment.

Stigmatising attitudes of laypersons toward patients with alopecia exist across a multitude of social and professional scenarios.7 The prevalence and magnitude of this stigma varies by alopecia severity.7 Stereotypes perceived include sickliness and unattractiveness and this may result in a feeling of being uncomfortable with physical contact with patients with alopecia.7

I don’t recognize myself in the mirror anymore. I feel self-conscious.”

View hypothetical patient profiles Loading

Mode of Action

References:

Villasante Fricke AC, Miteva M. Clin Cosmet Investig Dermatol. 2015;8:397-403Liu LY, King BA, Craiglow BG. J Am Acad Dermatol. 2018;79(3):556-558.e1Mesinkovska N, et al. J Investig Dermatol Symp Proc. 2020;20(1):S62-S68.Aldhouse NVJ, et alJ Patient Rep Outcomes. 2020;4(76)Davey L, Clarke V, Jenkinson E. Br J Dermatol. 2019;180(6):1377-1389Christensen T, Yang JS, Castelo-Soccio L. Skin Appendage Disord. 2017;3(3):115-118Creadore A et al. JAMA Dermatol. 2021;157(4);392-298
PP-LGF-GBR-0260. May 2025

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search 

for MHRA Yellow Card in Google Play or Apple App Store

 

Adverse events should also be reported to Pfizer Medical Information on 01304 616161

PfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign In or RegisterAccountSign Out

This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc

 

This website is brought to you by Pfizer Limited, a company registered in England 

and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ

 

Copyright © 2025 Pfizer Limited. All rights reserved.

 

VAT registration number GB201048427

PP-UNP-GBR-11245. January 2025
For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-UNP-GBR-7812. January 2024.

YesNo
You are now leaving PfizerPro​​​​​

You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site.

PP-UNP-GBR-12070. April 2025​​​​​​​
​​​​​​​
You are now leaving PfizerPro

​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site other than the information or other materials relating to ​​​​​Pfizer's medicines or business which it has provided or reviewed.

PP-UNP-GBR-12107. April 2025
​​​​​​​